David Fajgenbaum

David Fajgenbaum, MD, MBA, MSc, serves as an Associate Professor of Medicine in Translational Medicine & Human Genetics at the University of Pennsylvania School of Medicine, recognized as one of the youngest tenured professors in Penn Medicine's history. Fajgenbaum is the founding director of the Center for Cytokine Storm Treatment & Laboratory and leads a 15-member translational research laboratory, while also holding positions as Associate Director of Patient Impact at the Penn Orphan Disease Center and on the Leadership Council of the Colton Center for Autoimmunity. With over 75 published papers and more than $16 million in research funding, Fajgenbaum has advanced 16 repurposed treatments. In addition, Fajgenbaum co-founded Every Cure and serves as a board member for Creyon Bio and the Reagan-Udall Foundation for the FDA. Fajgenbaum also co-founded and presides over the Castleman Disease Collaborative Network and previously co-founded the National Students of AMF Support Network. Academic credentials include an MD from the University of Pennsylvania School of Medicine, an MBA from The Wharton School, and an MSc from the University of Oxford.